Cleared Traditional

K771683 - AMPLIFIER MODEL N3B-EEG (FDA 510(k) Clearance)

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K771683 · Honeywell, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1977
Decision
14d
Days
Class 2
Risk

K771683 is an FDA 510(k) clearance for the AMPLIFIER MODEL N3B-EEG. Classified as Amplifier, Physiological Signal (product code GWL), Class II - Special Controls.

Submitted by Honeywell, Inc. (Walker, US). The FDA issued a Cleared decision on September 20, 1977 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1835 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Honeywell, Inc. devices

Submission Details

510(k) Number K771683 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 06, 1977
Decision Date September 20, 1977
Days to Decision 14 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
134d faster than avg
Panel avg: 148d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GWL Amplifier, Physiological Signal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1835
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWL Amplifier, Physiological Signal

All 52
Devices cleared under the same product code (GWL) and FDA review panel - the closest regulatory comparables to K771683.
Delphi Amplifier
K243746 · Quantalx Neroscience · Mar 2025
NExT Station
K242832 · Eb Neuro S.P.A. · Dec 2024
DreamClear
K240646 · Somnomed Technologies Inc., Doing Business AS Remware · Sep 2024
BE Plus PRO, Neurotravel LIGHT
K242305 · Eb Neuro S.P.A. · Sep 2024
X-trodes System M
K232210 · X-Trodes · Feb 2024
Vlab
K230148 · Dormotech Medical, Ltd. · Oct 2023